Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05597553
Other study ID # PM Mta verses P/L
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date December 1, 2023

Study information

Verified date December 2022
Source Cairo University
Contact Aisha MK Magdy, BDS
Phone 01060259375
Email aisha.abozaid@dentistry.cu.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluate Clinical and Radiographic Evaluation of Premixed verses Powder / Liquid Bioceramic Mineral Trioxide Aggregate in Indirect Pulp Capping of Immature Permanent Mandibular Molars


Description:

Mineral trioxide aggregate (MTA) is a bioactive, biocompatible, antibacterial material with good stability, and excellent sealing ability that has been used as a dressing material in pulp capping procedures in permanent teeth. Although it has good properties, MTA has many limitations, including long setting time, handling property and tooth discoloration making the use of this material challenging for many clinicians. Researchers and manufacturers have made progress in overcoming these problems in recent years, new and improved products are becoming available such as the premixed bioceramic putty. The premixed bioceramics putty are ready to use materials, fast setting, with superior handling properties and hydrophilic in nature that necessitate moisture from the adjacent tissues to set. They have advantage of insensitive to moisture and blood contamination with less technique sensitive. Upon setting, they become hard and expand slightly providing with superior long-term seal. Premixed Bio-ceramics (BC) are highly alkaline materials (pH = 12.7), they release calcium and have antibacterial activity. Their biocompatibility is higher than that of MTA, this is attributed to the absence of heavy metals from the premixed BC components. The premixed bio-ceramic putty (Well-Rootâ„¢ PT) has been developed for the management of pulp capping procedures with the advantage of uniform homogenous consistency and lack of waste. It is radiopaque material based on a calcium aluminosilicate composition. It has excellent biological & physical properties and does not shrink during setting. Well-Rootâ„¢ PT does not create an inflammatory response and promotes mineralization.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 24
Est. completion date December 1, 2023
Est. primary completion date January 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 8 Years
Eligibility Inclusion Criteria: - Medically fit and cooperative children. - Pediatric patients aged 6-8 years. - Deep caries with reversible pulpits in immature first permanent mandibular molars indicated for indirect pulp capping. - Absence of clinical signs and symptoms of pulpal exposure. - Absence of radiographic signs and symptoms of pulp degeneration. - Positive parental informed consent. Exclusion Criteria: - Clinical symptoms of irreversible pulpitis requiring endodontic treatment. - Clinical symptoms of pulp exposure. - The presence of fistulas or swelling.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Premixed MTA
The premixed Bio-ceramic putty during setting become hard and expand slightly providing a superior long-term seal
Powder/liquid MTA
Mineral trioxide aggregate (MTA) is a silicate material that is said to aid in faster bridge formation with fewer tunnel defects, less pulpal inflammation, and the maintenance of pulpal integrity. It is widely used in pediatric dentistry due to its excellent sealing properties.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

References & Publications (3)

Abdelmotelb MA, Gomaa YF, Khattab NMA, Elheeny AAH. Premixed bioceramics versus mineral trioxide aggregate in furcal perforation repair of primary molars: in vitro and in vivo study. Clin Oral Investig. 2021 Aug;25(8):4915-4925. doi: 10.1007/s00784-021-03 — View Citation

Motwani N, Ikhar A, Nikhade P, Chandak M, Rathi S, Dugar M, Rajnekar R. Premixed bioceramics: A novel pulp capping agent. J Conserv Dent. 2021 Mar-Apr;24(2):124-129. doi: 10.4103/JCD.JCD_202_20. Epub 2021 Oct 9. — View Citation

Torabinejad M, Parirokh M, Dummer PMH. Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part II: other clinical applications and complications. Int Endod J. 2018 Mar;51(3):284-317. doi: 10.1111/iej.12843. Epub 2017 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Post operative pain Clinical examination by(Visual Analogue Scale) System (0 - Mild - Moderate - Severe) 12months
Secondary Pulp vitality Evaluate of pulp vitality by Electrical pulp test 9Normal response, Exaggerated brief Exaggerated prolong, Negative) 12months
Secondary Absence of furcal radiolucency or root resorption Evaluate Periapical Intraoral Digital Radiography if present or absent 12months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05928858 - Clinical And Radiographic Evaluation Of Premixed Bio-ceramic MTA In Indirect Pulp Capping Of Young Permanent Molars Phase 3
Completed NCT05167123 - Pulp Capping in Primary Molars Using TheraCal (LC) Phase 4
Active, not recruiting NCT05554952 - Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries N/A
Completed NCT04236830 - Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars Phase 2/Phase 3
Not yet recruiting NCT06433297 - Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars N/A
Active, not recruiting NCT04018716 - Clinical Performance of MTA Cavity Lining in the Treatment of Deep Caries Lesions N/A
Recruiting NCT03741816 - Indirect Pulp Capping With Biodentine and TheraCal LC in Permanent Mature Molars N/A
Completed NCT06325540 - Clinical Success of Indirect Pulp Capping: 1-Year Follow-Up N/A